ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
4,967.23
-0.88%
US Tech 100
16,556.80
-2.24%
Dow Jones
37,986.40
0.56%
Brent Oil
86.625
0.00%
Bitcoin
63,752.84
-0.13%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Clearside Biomedical Inc (CLSD) Quote

Clearside Biomedical Inc

Clearside Biomedical Inc (CLSD)

NASDAQ
1.31
-0.01
(-0.76%)
Closed April 19 4:00PM
Delayed by 15 minutes
1.25
-0.06
(-4.58%)
After Hours: 6:31PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.25
Bid
1.25
Ask
1.31
Volume
228,503
1.25 Day's Range 1.45
0.650101 52 Week Range 2.12
Market Cap
98.632M
Previous Close
1.32
Open
1.33
Last Trade
200
@
1.25
(formt)
Last Trade Time
Financial Volume
$ 305,121
VWAP
1.3353
Average Volume (3m)
377,227
Shares Outstanding
74,721,139
Dividend Yield
-
PE Ratio
-3.04
Earnings Per Share (EPS)
-0.43
Revenue
8.23M
Net Profit
-32.49M

About Clearside Biomedical Inc

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual functio... Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.clearsidebio.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Clearside Biomedical Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLSD. The last closing price for Clearside Biomedical was $1.32. Over the last year, Clearside Biomedical shares have traded in a share price range of $ 0.650101 to $ 2.12.

Clearside Biomedical currently has 74,721,139 shares outstanding. The market capitalization of Clearside Biomedical is $98.63 million. Clearside Biomedical has a price to earnings ratio (PE ratio) of -3.04.

CLSD Latest News

More News

Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors

ALPHARETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye...

April 16 2024
GlobeNewswire Inc.

Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

ALPHARETTA, Ga., April 02, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye...

April 02 2024
GlobeNewswire Inc.

Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer

ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye...

March 18 2024
GlobeNewswire Inc.

Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

- Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 - - Partner Programs Continue to Report Positive Clinical Data Utilizing SCS Microinjector®...

March 12 2024
GlobeNewswire Inc.

Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024

ALPHARETTA, Ga., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...

February 29 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 08 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

February 08 2024
Edgar (US Regulatory)

Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering

ALPHARETTA, Ga., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside” or the “Company”) (NASDAQ: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies...

February 07 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 01 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

January 19 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.04-3.10077519381.291.451.12986651.2541874CS
4-0.52-29.37853107341.771.81.13067981.40833739CS
120.021.626016260161.232.121.13772271.5541422CS
260.4352.43902439020.822.120.6501012811521.38514098CS
520.1210.61946902651.132.120.6501011965091.29622854CS
156-1.46-53.87453874542.717.730.6501015589753.42129437CS
2600.021.626016260161.237.730.565852862.83610314CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.73
(101.62%)
36.52M
CSLRComplete Solaria Inc
$ 0.465319
(75.59%)
16.64M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.71k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
MNDRMobile health Network Solutions
$ 27.2386
(33.72%)
10.35M
YYAIConnexa Sports Technologies Inc
$ 0.8943
(-57.21%)
13.4M
SBFMSunshine Biopharma Inc
$ 1.77
(-46.69%)
11.9M
GTIGraphjet Technology
$ 6.43
(-33.09%)
95.33k
ISPCiSpecimen Inc
$ 0.2883
(-31.52%)
2.86M
BGLCBioNexus Gene Lab Corporation
$ 0.5998
(-29.32%)
735.88k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
SQQQProShares UltraPro Short QQQ
$ 12.84
(6.38%)
219.91M
AGBAAGBA Group Holding Ltd
$ 1.255
(21.84%)
128.79M
TQQQProShares UltraPro QQQ
$ 49.48
(-6.20%)
125.4M
SINTSiNtx Technologies Inc
$ 0.0414
(3.50%)
109.94M

CLSD Discussion

View Posts
BBANBOB BBANBOB 1 month ago
I'll suggest now that the GAP FILLED yesterday and it takes news 2-3 days to be digested, tomorrow we hopefully head back to the 2$ area, just my WAG bwthdik
👍️0
BBANBOB BBANBOB 1 month ago
WHO KNOWS PARD WHO KNOWS
👍️ 1
BBANBOB BBANBOB 1 month ago
.
👍️0
jhdf51 jhdf51 1 month ago
Great..well maybe just maybe we are finally on our way albeit perhaps a bumpy ride...

JHD
👍️0
BBANBOB BBANBOB 1 month ago
JHD

NOT really GAP filled and has held up very well, next surge is on its way and still say this will close on FRI over $2

Vol is holding UPPPPPPPP well so, something is up here, from 2.12 to 1.47 was a major head fake to close the gap imho and probably casue a lot to part with some shares WHIH imho is exactly what they wanted...............
👍️0
jhdf51 jhdf51 1 month ago
Same ol same ol
👍️0
BBANBOB BBANBOB 1 month ago
WE BOTH HAVE THE SAME PROBLEM

DNDN been there done that and not again
👍️ 1
BBANBOB BBANBOB 1 month ago
.53 cent loss versus .55 loss last yr
👍️0
jhdf51 jhdf51 1 month ago
Yep..I was thinking of getting out but same...
👍️0
BBANBOB BBANBOB 1 month ago
Not REAL THRILLED with the earnings to be released AH's that is normally indicative of bad numbers, so looks like the 2.12 was a head fake for some to get out
I came close to selling 50% yesterday and get back in when it closes the gap @ 1.54,,,,,,, but just couldn't find the CAJONES to do it..........OH WELL NO BALLS NO BLACK CHIPS
👍️0
BBANBOB BBANBOB 1 month ago
Appears they are playing this real hard to get shares all the way to 1.81 from 2.12
👍️0
BBANBOB BBANBOB 1 month ago
1.87 NEW annual high and HOD. 3 trade days ago we did 3 mill shares and VOL proceeds PPS

MY WAG is this is over 2$ by weeks end.

AND NO not pumping this since I have held it for over 2 yrs NOV of 2022 and @ $4.86 finally got my avg to $2.00
👍️0
Monksdream Monksdream 1 month ago
CLSD 10Q due March 12
👍️0
Monksdream Monksdream 1 month ago
CLSD new 52 week hi
👍️0
glenn1919 glenn1919 1 month ago
CLSD....................................................https://stockcharts.com/h-sc/ui?s=CLSD&p=W&b=5&g=0&id=p86431144783
👍️0
BBANBOB BBANBOB 1 month ago
And on VERY GOOD VOL, me thinks something is up
👍️0
Monksdream Monksdream 1 month ago
CLSD new 52 week high
👍️0
Monksdream Monksdream 2 months ago
CLSD under $2
👍️0
BBANBOB BBANBOB 3 months ago
OOOOOOOOOOOOOPS $1.47
👍️0
BBANBOB BBANBOB 6 months ago
OPPPPPPPPPPPPPPS .6951
👍️0
BBANBOB BBANBOB 6 months ago
APPEARS we just made a new one too DAMN @ .70

I'm hoping they are tanking it in front of good earning to pick it up I KNOWWWWWWWWWWWWWWWWWWWWWWWWWWWW
👍️0
Monksdream Monksdream 7 months ago
CLSD new 52 week low
👍️0
Monksdream Monksdream 7 months ago
CLSD new 52 week low
👍️0
Monksdream Monksdream 7 months ago
CLSD new 52 week low
👍️0
Monksdream Monksdream 7 months ago
CLSD new 52 week low
👍️0
heyitsmeagain heyitsmeagain 2 years ago
Here we go
👍️0
heyitsmeagain heyitsmeagain 2 years ago
Loaded for this runner. Wish I had more loot.
👍️0
BBANBOB BBANBOB 2 years ago
Hard to Borrow is back on CLSD today
👍️0
BBANBOB BBANBOB 2 years ago
FYI

THE HARD TO BORROW classification(at Schwab) just went POOF GHONDI as of today on CLSD and at the same time its is up 3.81%

HMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMM
👍️0
BBANBOB BBANBOB 2 years ago
Well so far so good !!!!!!!!!!!!!!!!!! Let's say for grins $3 on Fri
👍️0
BBANBOB BBANBOB 2 years ago
Well well let's give this news 2-3 days to digest and see where it is by weeks end.

Also if if if this is gonna take off as I believe, the first part of the week MIGHT JUST SCARE THE WEAK here.

If you're faint at heart or can't handle pressure, one might want to JUST NOT LOOK for the next few days
👍️0
jhdf51 jhdf51 2 years ago
Now that would be perfect. I’d hire me a farm hand, or two, or three! Lol

JHD
👍️0
BBANBOB BBANBOB 2 years ago
Again

Earnings was a beat and they were .31 for the LAST quarter PER SHARE, do that X's a whole yr and then X's a multiple of 10-12 and there ya have it.

NOW Since this appears to be JUST the start of licensing, who knows how many more licenses will be entered into in the next year.

MY PPS prediction would be along the lines of $27-$35 in the next 12 months WAG and IMHO
👍️0
jhdf51 jhdf51 2 years ago
Yes I agree. Definitely could be. Dang Price targets are never exact anyway.
👍️0
BBANBOB BBANBOB 2 years ago
I'll take $9 for this year, but still say it will be more.
👍️0
jhdf51 jhdf51 2 years ago
I see $9. $18 was last year.

https://www.google.com/amp/s/www.marketbeat.com/instant-alerts/nasdaq-clsd-a-buy-or-sell-right-now-2022-03-2/amp/
👍️0
BBANBOB BBANBOB 2 years ago
But all companies good or bad always have HEDGE FUNDS that short their stock, THUS the meaning of HEDGE, being on both sides of the trade, much like a BOOKIE taking sports bets will take EITHER SIDE of a bet.

BUT unlike a bookie that takes your bet and at half time IS WAY UPSIDE down on the bet he made with you, HE DOES NOT HAVE THE OPPORTUNITY to CHANGE his bet, SHORTS DO at any given time

THUNK ABOUT IT BOYZZZZZZZZZZZ
👍️0
BBANBOB BBANBOB 2 years ago
SHORTS

Again as I did last week, I would serious suggest that you close even the few shorts you have still open here, as it might get REAL NASTY if ya don't, JUST SAYING
👍️0
BBANBOB BBANBOB 2 years ago
Having NOT been able to take part in PICKING UP SHARES last week, I just got back to even as of today at one point. IF IF IF it closes over 2.39 today, then FINALLY again I am BACK in the black.
👍️0
BBANBOB BBANBOB 2 years ago
Well YET AGAIN it seems my 3 day rule on it taking 3 days for news to be fully digested before a stock rises,has yet again proven itself true..
👍️0
BBANBOB BBANBOB 2 years ago
CRUDEOIL

I have always suggested on these boards that, ""IT TAKE 3 days for news to be really digested before ya see real up swings, HMMMMMMMM
👍️0
BBANBOB BBANBOB 2 years ago
OH I agree 100% and suggested that ALL for the last months JUST SIT ON THEIR HANDS or add.....

Me aint got no dry powder or I would have last week and large
👍️0
crudeoil24 crudeoil24 2 years ago
Good earnings, & good technical indicators > CLSD momo/fomo taking us higher!
👍️0
BBANBOB BBANBOB 2 years ago
YEPPERS and so we have 4 months left there to meet the 1 yr
👍️0
crudeoil24 crudeoil24 2 years ago
Wedbush target is $18.00 > their PT is for one year!

CLSD
👍️0
jhdf51 jhdf51 2 years ago
No worries bud. I just appreciate being here and I believe we will see that raised by Wedbush again.

JHD
👍️0
BBANBOB BBANBOB 2 years ago
JHD

Thanks for the correction, sad we have some that POST OLD CHIT and even more sad THAT I DIDN'T CHECK it out further and took the bait and ran with it................................MY BAD !!!!!!!!!!!!

Still say though simply take .31 X's 4 ='s $1.24 and do that X's a PE of say 10 to 12 X's and you're pretty much there anyway......

Let the news digest for the 3 day rule (MY RULE) and see what the NEW ESTIMATES will be.........

Thank you again for keeping it straight that is all I want
👍️0
jhdf51 jhdf51 2 years ago
Yes from 2021. Currently $9 >> https://www.etfdailynews.com/2022/03/12/clearside-biomedical-nasdaqclsd-given-outperform-rating-at-wedbush/
👍️0
jhdf51 jhdf51 2 years ago
In 2021 they targeted at $18 but not currently….. though perhaps with time.

JHD
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 2 years ago
$CLSD on watch next week..chart breaking out here..

https://stockcharts.com/c-sc/sc?s=CLSD&p=D&b=5&g=0&i=0&r=1647094106305
👍️0

Your Recent History

NASDAQ
CLSD
Clearside Biomedical
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved